HealthStream, Inc. (HSTM)
NASDAQ: HSTM · Real-Time Price · USD
20.34
-0.03 (-0.15%)
At close: Apr 14, 2026, 4:00 PM EDT
20.34
0.00 (0.00%)
After-hours: Apr 14, 2026, 4:10 PM EDT
HealthStream Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for HealthStream stock has a target of 28, which predicts a 37.66% increase from the current stock price of 20.34.
Price Target: $28 (+37.66%)
Analyst Consensus: Hold
* Price targets were last updated on Dec 17, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for HealthStream is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $28 | Hold | Maintains | $28 | +37.66% | Dec 17, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $29 → $28 | Hold | Maintains | $29 → $28 | +37.66% | Aug 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $30 → $29 | Hold | Maintains | $30 → $29 | +42.58% | May 15, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $29 → $30 | Hold | Maintains | $29 → $30 | +47.49% | Feb 26, 2025 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 6, 2025 |
Financial Forecast
Revenue This Year
332.81M
from 304.06M
Increased by 9.45%
Revenue Next Year
349.85M
from 332.81M
Increased by 5.12%
EPS This Year
0.75
from 0.61
Increased by 22.40%
EPS Next Year
0.84
from 0.75
Increased by 12.02%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 345.3M | 362.9M | |||
| Avg | 332.8M | 349.9M | |||
| Low | 318.2M | 332.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 13.5% | 9.0% | |||
| Avg | 9.5% | 5.1% | |||
| Low | 4.6% | -0.0% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | 0.80 | 0.89 |
| Avg | 0.75 | 0.84 |
| Low | 0.71 | 0.77 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | 30.8% | 19.5% |
| Avg | 22.4% | 12.0% |
| Low | 15.7% | 3.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.